Evaluation of HIV Drug Interaction Web Sites

Annals of Pharmacotherapy

Volumn 37, Issue 11, 2003, Pages 1577-1586

  Sheehan, Nancy L ^a,g   Kelly, Deborah V ^b   Tseng, Alice L ^c   Van Heeswijk, Rolf P G ^d   Béïque, Lizanne C ^e   Hughes, Christine A ^f  

^a MCGILL UNIVERSITY   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Drug interactions; HIV; Internet; Web site

Indexed keywords

ALCOHOL; AMPRENAVIR; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; CANNABIS; CYTOCHROME P450; DELAVIRDINE; GARLIC EXTRACT; GLUCURONOSYLTRANSFERASE; GLYCOPROTEIN P; HERBACEOUS AGENT; INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; AWARENESS; DRUG INFORMATION; DRUG SCREENING; HERBAL MEDICINE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNET; PATIENT EDUCATION; PRIORITY JOURNAL; RELIABILITY;

ANTI-RETROVIRAL AGENTS; DRUG INTERACTIONS; HUMANS; INFORMATION DISSEMINATION; INTERNET;

EID: 0142213616     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D039     Document Type: Article

References (22)

1. Tseng AL, Foisy MM. Management of drug interactions in patients with HIV. Ann Pharmacother 1997;31:1040-58.
2. Tseng AL, Foisy MM. Significant interactions with new antiretrovirals and psychotropic drugs. Ann Pharmacother 1999;33:461-73.
3. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St. John's wort. Lancet 2000;355:547-8.
4. Piscitelli SC, Burstein AH, Welden N, Gallicano K, Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002;34:234-8.
5. Kupferschmidt HHT, Fattinger KE, Ha HR, Follath F, Kraehenbuehl S. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br J Clin Pharmacol 1998;45:355-9.
6. Henry JA, Hill IR. Fatal interaction between ritonavir and MDMA. Lancet 1998;352:1751-2.
7. Harrington RD, Woodward JA, Hooton TM, Horn JR. Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate. Arch Intern Med 1999;159:2221-4.
8. Fung HB, Stone EA, Piacenti FJ. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection. Clin Ther 2002;24:1515-48.
9. Impicciatore P, Pandolfini C, Casella N, Bonati M. Reliability of health information for the public on the world wide web: systematic survey of advice on managing fever in children at home. BMJ 1997;314:1875-9.
10. Griffiths KM, Christensen H. Quality of web based information on treatment of depression: cross sectional survey. BMJ 2000;321:1511-5.
11. Gottlieb S. Health information on Internet is often unreliable. BMJ 2000;321:136.
12. Hsu A, Granneman GR, Cao G, Carothers L, Japour A, El-Shourbagy T, et al. Pharmacokinetic interaction between ritonavir and indinavir in healthy volunteers. Antimicrob Agents Chemother 1998;42:2784-91.
13. Hsu A, Granneman GR, Heath-Chiozzi M, Ashbrenner E, Manning L, Brooks R, et al. Indinavir can be taken with regular meals when administered with ritonavir (abstract 22361). Presented at: 12th World AIDS Conference, Geneva, June 28-July 3, 1998.
14. Tran JQ, Petersen C, Garrett M, Schultz-Smith M, Lillibridge JH, Kerr BM. Delavirdine significantly increases plasma concentrations of amprenavir in healthy volunteers (abstract P266). AIDS 2000;14(suppl):S92.
15. Justesen U, Klitgaard N, Brosen K, Pedersen C. Amprenavir is an effective inducer of delavirdine metabolism: a steady-state pharmacokinetic interaction study between amprenavir and delavirdine in healthy volunteers (abstract 442-W). Presented at: 9th Conference on Retroviruses and Opportunistic Infections, Seattle, February 24-28, 2002:220.
16. Kosel BW, Aweeka FT, Benowitz NL, Shade SB, Hilton JF, Lizak PS, et al. The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir. AIDS 2002;16:543-50.
17. Wilson P. How to find the good and avoid the bad or ugly: a short guide to tools for rating quality of health information on the Internet. BMJ 2002;324:598-602.
18. Kim P, Eng TR, Deering MJ, Maxfield A. Published criteria for evaluating health related web sites: review. BMJ 1999;318:647-9.
19. Wyatt JC. Commentary: measuring quality and impact of the world wide web. BMJ 1997;314:1879-81.
20. Health Information Technology Institute. Criteria for assessing the quality of health information on the Internet. January 18, 2001. www.mitretek. org/hiti/showcase/documents/criteria.html (accessed 2002 Mar).
21. BIOME Special Advisory Group on Evaluation. How to evaluate an Internet-based information source. December 18, 2001. www.biome.ac.uk/ guidelines/eval/howto.html (accessed 2002 Mar).
22. Smith A. Criteria for evaluation of Internet information resources. March 2, 1997. www.vuw.ac.nz/∼agsmith/evaln/index.htm (accessed 2002 Mar).